Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EndPoint BioCapital is a venture capital and private equity firm based in Kuala Lumpur, Malaysia, that specializes in investments within the life sciences and biotechnology sectors. The firm provides strategic capital and advisory services to emerging healthcare companies, particularly those focused on drug development and medical technology. It is known for its advisory board, which includes experienced industry veterans such as Anthony Maida, and has been active in the global biotech investment landscape since the late 1990s. The firm's expertise spans clinical development, regulatory affairs, and corporate finance, helping its portfolio companies navigate the complexities of bringing new therapies to market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EndPoint BioCapital.